Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE [انترنت]. 27 فبراير، 2025 [وثق 25 أغسطس، 2026];3(1). موجود في: https://shmpublisher.com/index.php/johmpe/article/view/547